Copyright Reports & Markets. All rights reserved.

Global Breast Cancer Predictive Genetic Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 High Penetrant Genes
    • 1.4.3 Intermediate Penetrant Genes
    • 1.4.4 Low Penetrant Genes
  • 1.5 Market by Application
    • 1.5.1 Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2015-2026)
  • 2.2 Global Breast Cancer Predictive Genetic Testing Growth Trends by Regions
    • 2.2.1 Breast Cancer Predictive Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Breast Cancer Predictive Genetic Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Breast Cancer Predictive Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Market Size
    • 3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio
    • 3.2.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2019
  • 3.3 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served
  • 3.4 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
  • 3.5 Date of Enter into Breast Cancer Predictive Genetic Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)
  • 5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 6.2 Breast Cancer Predictive Genetic Testing Key Players in North America (2019-2020)
  • 6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 7.2 Breast Cancer Predictive Genetic Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 8.2 Breast Cancer Predictive Genetic Testing Key Players in China (2019-2020)
  • 8.3 China Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 8.4 China Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 9.2 Breast Cancer Predictive Genetic Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 9.4 Japan Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 10.2 Breast Cancer Predictive Genetic Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 11.2 Breast Cancer Predictive Genetic Testing Key Players in India (2019-2020)
  • 11.3 India Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 11.4 India Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)
  • 12.2 Breast Cancer Predictive Genetic Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Roche
    • 13.1.1 Roche Company Details
    • 13.1.2 Roche Business Overview
    • 13.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction
    • 13.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020))
    • 13.1.5 Roche Recent Development
  • 13.2 Thermo Fisher Scientific
    • 13.2.1 Thermo Fisher Scientific Company Details
    • 13.2.2 Thermo Fisher Scientific Business Overview
    • 13.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction
    • 13.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.2.5 Thermo Fisher Scientific Recent Development
  • 13.3 PerkinElmer
    • 13.3.1 PerkinElmer Company Details
    • 13.3.2 PerkinElmer Business Overview
    • 13.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction
    • 13.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.3.5 PerkinElmer Recent Development
  • 13.4 Quest Diagnostics
    • 13.4.1 Quest Diagnostics Company Details
    • 13.4.2 Quest Diagnostics Business Overview
    • 13.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction
    • 13.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.4.5 Quest Diagnostics Recent Development
  • 13.5 Myriad Genetics
    • 13.5.1 Myriad Genetics Company Details
    • 13.5.2 Myriad Genetics Business Overview
    • 13.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction
    • 13.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.5.5 Myriad Genetics Recent Development
  • 13.6 Iverson Genetics
    • 13.6.1 Iverson Genetics Company Details
    • 13.6.2 Iverson Genetics Business Overview
    • 13.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction
    • 13.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.6.5 Iverson Genetics Recent Development
  • 13.7 Cancer Genetics
    • 13.7.1 Cancer Genetics Company Details
    • 13.7.2 Cancer Genetics Business Overview
    • 13.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction
    • 13.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.7.5 Cancer Genetics Recent Development
  • 13.8 OncoCyte Corporation
    • 13.8.1 OncoCyte Corporation Company Details
    • 13.8.2 OncoCyte Corporation Business Overview
    • 13.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction
    • 13.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.8.5 OncoCyte Corporation Recent Development
  • 13.9 NeoGenomics
    • 13.9.1 NeoGenomics Company Details
    • 13.9.2 NeoGenomics Business Overview
    • 13.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction
    • 13.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.9.5 NeoGenomics Recent Development
  • 13.10 Invitae
    • 13.10.1 Invitae Company Details
    • 13.10.2 Invitae Business Overview
    • 13.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction
    • 13.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)
    • 13.10.5 Invitae Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Breast Cancer Predictive Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Predictive Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Roche
    Thermo Fisher Scientific
    PerkinElmer
    Quest Diagnostics
    Myriad Genetics
    Iverson Genetics
    Cancer Genetics
    OncoCyte Corporation
    NeoGenomics
    Invitae

    Market segment by Type, the product can be split into
    High Penetrant Genes
    Intermediate Penetrant Genes
    Low Penetrant Genes
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now